We are live on
!
Find out more
GP
GSK plc Portfolio holdings
AUM
$599M
This Fund
S&P 500
This Quarter
Est. Return
-12.19%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$599M
AUM Growth
-$200M
(-25%)
Cap. Flow
-$67.4K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
97.33%
Holding
15
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Senseonics Holdings Inc
SENS
|
+$59.9K |
| 2 |
Harvard Bioscience
HBIO
|
+$7.46K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.99B
| $153M | 25.57% |
3,220,627
| – | – |
|
2
Wave Life Sciences
WVE
$1.14B
| $132M | 22.08% |
18,245,691
| – | – |
|
3
BioNTech
BNTX
$22.8B
| $79.1M | 13.2% |
889,824
| – | – |
|
4
Vir Biotechnology
VIR
$1.64B
| $76.6M | 12.79% |
8,550,954
| – | – |
|
5
IDEAYA Biosciences
IDYA
$3.48B
| $44.4M | 7.41% |
1,333,333
| – | – |
|
6
Lyell Immunopharma
LYEL
$334M
| $30.3M | 5.06% |
1,512,659
| – | – |
|
7
Cytokinetics
CYTK
$11.2B
| $22.4M | 3.75% |
340,434
| – | – |
|
8
Spero Therapeutics
SPRO
$126M
| $21.5M | 3.59% |
9,190,606
| – | – |
|
9
Fulcrum Therapeutics
FULC
$236M
| $13.7M | 2.29% |
1,785,714
| – | – |
|
10
CVRx
CVRX
$144M
| $9.53M | 1.59% |
1,007,583
| – | – |
|
|
BCYC
11
Bicycle Therapeutics
BCYC
$304M
| $7.1M | 1.18% |
1,529,561
| – | – |
|
12
Nkarta
NKTX
$200M
| $6.65M | 1.11% |
3,150,732
| – | – |
|
13
Regenxbio
RGNX
$659M
| $2.27M | 0.38% |
271,456
| – | – |
|
|
14
Harvard Bioscience
HBIO
$27.6M
| – | – |
-1,115
| Closed | -$7.46K |
|
|
15
Senseonics Holdings Inc
SENS
$276M
| – | – |
-10,856
| Closed | -$59.9K |
|
Similar funds
BHPW
SCM
CCP
FSG
CNBTD
CTA
ECM
OCAM